Can-Fite-s Level II ADRs Commence Trading on the U.S. OTC Markets
Commercial & Investment Banking, Picture Gallery Thursday, September 12th, 2013
PETACH TIKVA, ISRAEL — (Marketwired) — 09/12/13 — (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its shares have been approved for trading as a Level II American Depositary Receipt ("ADR") program on the U.S. Over-the-Counter Markets (the "OTC Markets"). The Company-s shares were previously traded as a Level I ADR program on the OTC Markets. Can-F
